Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 19, 2019 - Issue 6
Submit an article Journal homepage
89
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Risk sharing or risk shifting? On the development of patient access schemes in the process of updating the national list of health services in Israel

Noa TrikiDepartment of Health Technology Policy, Maccabi Healthcare Services, Tel-Aviv, IsraelCorrespondence[email protected]
View further author information
,
Nachman AshMedical Division, Maccabi Healthcare Services, Tel-Aviv, Israel;The Department of Health Systems Management, Ariel University, Ariel, IsraelView further author information
,
Avi PorathDepartment of Public Health, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, IsraelView further author information
,
Yair BirnbaumClalit Health Services Headquarters, Tel-Aviv, IsraelView further author information
,
Dan GreenbergDepartment of Health Systems Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, IsraelView further author information
&
Ariel HammermanDepartment of Pharmaceutical Technology Assessment, Clalit Health Services Headquarters, Tel-Aviv, IsraelView further author information
Pages 749-753 | Received 26 Aug 2019, Accepted 05 Dec 2019, Published online: 11 Dec 2019

References

  • Walker S, Sculpher M, Claxton K, et al. Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions. Value Health. 2012 May;15(3):570–579.
  • Adamski J, Godman B, Ofierska-Sujkowaska, et al. Risk-sharing agreements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Serv Res. 2010;10:153.
  • Piatkiewicz TJ, Traulsen JM, Holm-Larsen T. Risk-sharing agreements in the EU: A systematic review of major trends. Pharmacoecon Open. 2018 Jun;2(2):109–123.
  • Yu JS, Chin L, Oh J, et al. Performance-based risk-sharing arrangements for pharmaceutical products in the United States: A systematic review. J Manag Care Spec Pharm. 2017 Oct;23(10):1028–1040.
  • Rosen B, Waitzberg R, Merkur S. Israel: health system review. Health Syst Transit. 2015;17(6):1–212.
  • Greenberg D, Siebzehner MI, Pliskin JS. The process of updating the national list of health services in Israel: is it legitimate? Is it fair? Int J Technol Assess Health Care. 2009 Jul;25(3):255–261.
  • Hammerman A, Feder-Bubis P, Greenberg D. Financial risk-sharing in updating the national list of health services in Israel: stakeholders’ perceived interests. Value Health. 2012 Jul-Aug;15(5):737–742.
  • Gavious A, Greenberg D, Hammerman A, et al. Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach. Eur J Health Econ. 2014 Jun;15(5):553–561.
  • Adijes-Toren A, Brammli-Greenberg S. Patients oriented access scheme-learning from the success of the Israeli innovative solution for the escalating drug prices. Value Health. 2017;20: A690. (abstract).
  • Gonçalves FR, Santos S, Silva C, et al. Risk-sharing agreements, present and future. Ecancermedicalscience. 2018 Apr;10(12):823.
  • Abadi-Korek I, Shemer J. Risk-sharing scheme in Israel–kuvan as an allegory. Harefuah. 2012 Jun;151(6):362–3, 377, 376. Hebrew.
  • Yassor-Beith Orr M The basket was approved- for the first-time smoking cessation drugs are reimbursed. Ynet ( Hebrew). [ updated 2009 Dec 23; cited 2019 Aug 16]. Available from: https://www.ynet.co.il/articles/0,7340,L-3823992,00.html
  • The Knesset Research and Information Center. Coping with hepatitis C in Israel 2014–2018. ( Hebrew). [ updated 2018 Oct 14; cited 2019 Oct 15]. Available from: https://fs.knesset.gov.il/globaldocs/MMM/3359dfa2-7a53-e811-80e1-00155d0a9876/2_3359dfa2-7a53-e811-80e1-00155d0a9876_11_12374.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.